Norway· NO-ID_956DE420-B3AF-4025-BAAC-504E715F7A30
Nikotinamid NAF
A nicotinamide product containing nikotinamid, registered in Norway by Kragerø Tablettproduksjon AS. The same ATC class is registered in 8 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Nicotinamide is registered in 8 of 19 countries.
Countries holding a registration under ATC A11HA01 (nicotinamide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Nicotinamide · ATC A11HA01
8 / 19 countries
- Belgiumprice
- Franceprice
- Germany
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Nikotinamid
- Manufacturer
- Kragerø Tablettproduksjon AS
- Country
- Norway (NO)
- ATC code
- A11HA01
- ATC class
- Nicotinamide
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_956DE420-B3AF-4025-BAAC-504E715F7A30
- no_varenummer300509100
- gtin7045283005093
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
83 interactions on record for nicotinamide.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nicotinamide · interactions on record
83 records
- 7 severe
- 75 moderate
- 1 minor
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nicotinamide in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAceNic 50mg tabletsEssential-Healthcare Ltd
- PolandVitaminum PP 50 mg PolfarmexPolfarmex S.A.
- United States4 IN LOOK Ginseng Anit wrink Anti wrinkle essenceGuangzhou Yanhou Cosmetics Co., Ltd.
- FranceNICOBION 500 mg, comprimé pelliculéTEOFARMA
- BelgiumBecozymeBayer
- Japanニコチン酸アミドＮＩＳＳＨＡゾンネボード製薬
- GermanyNicotinamid AxicurAxicorp Pharma Gmbh
- IrelandNicam 4% w/w GelDermal Laboratories (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Nicotinamide Sterop
- Germany · Nicotinamid Axicur
- France · Nicobion, Nicotinamide Renaudin
- United Kingdom (Northern Ireland) · Freederm, Freederm Treatment
- Ireland · Nicam
- Italy · Nicotinamide Idi
- Poland · Vitaminum Pp Polfarmex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/756521f6-6a32-48bc-abe6-b8a357a75501 GET /v1/drugs/756521f6-6a32-48bc-abe6-b8a357a75501?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Nikotinamid",
"merkevare_id": "ID_956DE420-B3AF-4025-BAAC-504E715F7A30",
"name_form_strength": "Nikotinamid NAF tab 50 mg",
"prescription_group": "F"
}See everything about nicotinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.